Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture
Neostigmine and Glycopyrrolate for the Treatment of Post Dural Puncture Headache After Known Dural Puncture With a Tuohy Needle: A Pilot Study
Mayo Clinic
18 participants
Nov 19, 2021
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to evaluate Neostigmine and Glycopyrrolate to treat post-dural puncture headache (PDPH) to reduce the proportion of postpartum women with a PDPH requiring epidural blood patch (EBP) who developed a PDPH after accidental dural puncture.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
IV infusion 20 μg/kg over 10 minutes repeated every 8 hours for a maximum of 3 doses
IV infusion 4 μg/kg over 10 minutes repeated every 8 hours for a maximum of 3 doses
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05116930